Position in PFE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$116,732,294
+$19,731,233 QoQ
Shares Held
4,157,133
+6.7% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TD Asset Management Inc holds $4,569,308,928 across 12 Drug Manufacturers - General names. PFE ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,565,498 | $1,115,990,330 | |
| 2 | LLY |
ELI LILLY & Co
|
1,190,111 | $1,094,628,394 | |
| 3 | ABBV |
AbbVie Inc.
|
3,920,076 | $852,577,328 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,372,079 | $469,966,650 | |
| 5 | AZN |
Astrazeneca PLC
|
1,965,535 | $387,642,812 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,288,576 | $275,292,806 | |
| 7 | AMGN |
Amgen Inc
|
404,449 | $142,305,380 | |
| 8 | PFE |
Pfizer Inc
This page
|
4,157,133 | $116,732,294 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $116,732,294 | 4,157,133 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $97,001,061 | 3,895,625 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $92,992,750 | 3,649,637 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $89,162,694 | 3,678,329 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $77,934,563 | 3,075,555 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $73,141,246 | 2,756,926 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $78,155,334 | 2,700,599 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $72,268,813 | 2,582,874 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $68,849,553 | 2,481,065 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $69,474,530 | 2,413,148 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $97,662,330 | 2,944,297 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $124,830,366 | 3,403,227 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $152,455,727 | 3,736,660 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $460,108,810 | 8,979,485 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $407,594,905 | 9,314,326 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $492,127,955 | 9,386,381 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $464,720,031 | 8,976,628 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $460,996,854 | 7,806,890 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $155,469,665 | 3,614,733 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $131,733,260 | 3,363,975 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $115,259,368 | 3,181,324 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $116,511,674 | 3,165,218 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $106,965,526 | 3,071,983 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $157,612,518 | 5,080,227 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $326,598,989 | 10,546,440 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||